• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 41 of 100
Michigan Uses Drug Trafficking Law to Sue Walgreens and Other Opioid Distributors
HealthMichigan Uses Drug Trafficking Law to Sue Walgreens and Other Opioid Distributors
By David Eggert and The Associated PressDecember 17, 2019
Drugs and Tech Revolutionizinf Healthcare
HealthThe 4 Most Game-Changing Medical Advances of the Past Decade
By Sy MukherjeeDecember 17, 2019
Duchenne Sarepta FDA
NewslettersFDA Approves Sarepta Duchenne Drug in Stunning Reversal
By Sy MukherjeeDecember 13, 2019
New British Chief Executive Officer of French pharmaceutical group Sanofi Paul Hudson talks to journalists at Sanofi headquarters in Paris on October 1, 2019. (Photo by ERIC PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)
HealthWhy Sanofi’s New CEO Is Trading Diabetes Drugs for Cancer Breakthroughs
By James Paton and BloombergDecember 10, 2019
Cancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology
HealthCancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology
By Riley Griffin, James Paton and BloombergDecember 9, 2019
Paul Hudson, chief executive officer of Sanofi, gestures as he speaks during a panel session on the sidelines of the China International Import Expo (CIIE) in Shanghai, China, on Tuesday, Nov. 5, 2019. The CIIE -- now in its second year -- is designed to showcase the countrys desire to shift its economy toward consumption by buying more foreign goods. Photographer: Qilai Shen/Bloomberg via Getty Images
FinanceWhy Sanofi Is Buying a U.S. Cancer Biotech for Nearly 3 Times Its Market Value
By James Paton and BloombergDecember 9, 2019
Sanofi’s New CEO Readies Rx Plan For Pharma Giant
LeadershipSanofi’s New CEO Readies Rx Plan For Pharma Giant
By Susie GharibDecember 9, 2019
Biogen CEO on Controversial Alzheimer’s Drug: ‘There Is Hope’
LeadershipBiogen CEO on Controversial Alzheimer’s Drug: ‘There Is Hope’
By Susie GharibDecember 6, 2019
Biogen Alzheimers Drug Data
NewslettersThe Broader Implications of Biogen’s Divisive Alzheimer’s Drug
By Sy MukherjeeDecember 5, 2019
Diabetes medicine pills
HealthFDA Is Testing Diabetes Drug Metformin for NDMA, a Carcinogen
By John Lauerman and BloombergDecember 4, 2019
Astellas Gene Therapy Deal
NewslettersThe Gene Therapy Spree Rolls on With $3 Billion Astellas Deal
By Sy MukherjeeDecember 3, 2019
Biogen Stock Alzheimer's Aducanumab
NewslettersBiogen Stock Falls After Analyst Throws Cold Water on Its Alzheimer’s Drug Bet
By Sy MukherjeeDecember 2, 2019
A boy suffering from dengue fever rests under a mosquito net in a gymnasium
MagazineEpidemic of fear: How the trouble-ridden debut of a breakthrough vaccine sparked a panic
By Erika FryNovember 26, 2019
Novartis Amarin Cholesterol Drugs
NewslettersNovartis’ $9.7 Billion Deal Sets off Heart Drug Wars
By Sy MukherjeeNovember 25, 2019
American Vasant Narasimhan, CEO of Swiss pharmaceutical and drug maker Novartis speaks during a conference at the Fortune Global Forum event in Paris on Nov. 18, 2019. (Photo by ERIC PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)
FinanceNovartis Bets Big on Cholesterol Drug With $9.7 Billion Buyout of Medicines Co.
By James Paton and BloombergNovember 25, 2019
1...
  • 39
  • 40
  • 41
  • 42
  • 43
...100
Most Popular
Personal Finance
Social Security's 2032 deadline puts a 22% cut on the table — but Washington has way less room to negotiate than 1983placeholder alt text
By John W. Diamond and The ConversationJune 12, 2026
Success
CEO of $20 billion AI firm Perplexity says the secret to success is ‘sleeping with that fear’ that your competitor will steal your ideaplaceholder alt text
By Preston ForeJune 13, 2026
Economy
Boomers actually do hold most of the wealth and power. So why do they call it 'whiny' to point that out?placeholder alt text
By Nick LichtenbergJune 14, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.